BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10081961)

  • 1. Exploring protein interiors: the role of a buried histidine in the KH module fold.
    Fraternali F; Amodeo P; Musco G; Nilges M; Pastore A
    Proteins; 1999 Mar; 34(4):484-96. PubMed ID: 10081961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel RNA-binding motif: the KH module.
    Adinolfi S; Bagni C; Castiglione Morelli MA; Fraternali F; Musco G; Pastore A
    Biopolymers; 1999; 51(2):153-64. PubMed ID: 10397799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional structure and stability of the KH domain: molecular insights into the fragile X syndrome.
    Musco G; Stier G; Joseph C; Castiglione Morelli MA; Nilges M; Gibson TJ; Pastore A
    Cell; 1996 Apr; 85(2):237-45. PubMed ID: 8612276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome.
    Siomi H; Choi M; Siomi MC; Nussbaum RL; Dreyfuss G
    Cell; 1994 Apr; 77(1):33-9. PubMed ID: 8156595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of a clinically important mutation in the fold and RNA-binding properties of KH motifs.
    Ramos A; Hollingworth D; Pastore A
    RNA; 2003 Mar; 9(3):293-8. PubMed ID: 12592003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The KH module has an alpha beta fold.
    Castiglone Morelli MA; Stier G; Gibson T; Joseph C; Musco G; Pastore A; Travè G
    FEBS Lett; 1995 Jan; 358(2):193-8. PubMed ID: 7828735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains.
    Lewis HA; Chen H; Edo C; Buckanovich RJ; Yang YY; Musunuru K; Zhong R; Darnell RB; Burley SK
    Structure; 1999 Feb; 7(2):191-203. PubMed ID: 10368286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting FMR1, the protein responsible for fragile X syndrome, in its structural and functional domains.
    Adinolfi S; Bagni C; Musco G; Gibson T; Mazzarella L; Pastore A
    RNA; 1999 Sep; 5(9):1248-58. PubMed ID: 10496225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The solution structure of the first KH domain of FMR1, the protein responsible for the fragile X syndrome.
    Musco G; Kharrat A; Stier G; Fraternali F; Gibson TJ; Nilges M; Pastore A
    Nat Struct Biol; 1997 Sep; 4(9):712-6. PubMed ID: 9302998
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of a buried neutral histidine residue in Bacillus circulans xylanase: NMR assignments, pH titration, and hydrogen exchange.
    Plesniak LA; Connelly GP; Wakarchuk WW; McIntosh LP
    Protein Sci; 1996 Nov; 5(11):2319-28. PubMed ID: 8931150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dimerization in KH/RNA complexes: the example of Nova KH3.
    Ramos A; Hollingworth D; Major SA; Adinolfi S; Kelly G; Muskett FW; Pastore A
    Biochemistry; 2002 Apr; 41(13):4193-201. PubMed ID: 11914064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct contributions of KH domains to substrate binding affinity of Drosophila P-element somatic inhibitor protein.
    Chmiel NH; Rio DC; Doudna JA
    RNA; 2006 Feb; 12(2):283-91. PubMed ID: 16428607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of KH domains.
    Valverde R; Edwards L; Regan L
    FEBS J; 2008 Jun; 275(11):2712-26. PubMed ID: 18422648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into Fragile X syndrome. Relating genotype to phenotype at the molecular level.
    Pozdnyakova I; Regan L
    FEBS J; 2005 Feb; 272(3):872-8. PubMed ID: 15670167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of the nucleic-acid-binding activity of KH domains. Different properties of different domains.
    Dejgaard K; Leffers H
    Eur J Biochem; 1996 Oct; 241(2):425-31. PubMed ID: 8917439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of ERA: a GTPase-dependent cell cycle regulator containing an RNA binding motif.
    Chen X; Court DL; Ji X
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8396-401. PubMed ID: 10411886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome.
    Lewis HA; Musunuru K; Jensen KB; Edo C; Chen H; Darnell RB; Burley SK
    Cell; 2000 Feb; 100(3):323-32. PubMed ID: 10676814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KH domain-containing proteins of yeast: absence of a fragile X gene homologue.
    Currie JR; Brown WT
    Am J Med Genet; 1999 May; 84(3):272-6. PubMed ID: 10331606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dimensional NMR studies of the zinc finger motif: solution structures and dynamics of mutant ZFY domains containing aromatic substitutions in the hydrophobic core.
    Qian X; Weiss MA
    Biochemistry; 1992 Aug; 31(33):7463-76. PubMed ID: 1510933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatic-histidine interactions in the zinc finger motif: structural inequivalence of phenylalanine and tyrosine in the hydrophobic core.
    Jasanoff A; Weiss MA
    Biochemistry; 1993 Feb; 32(6):1423-32. PubMed ID: 8431422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.